Data Integrity, ALCOA+ & Part 11 / Annex 11

Handling Test Runs, Trial Batches and Exploratory Experiments in a DI-Compliant Way Step-by-Step Guide to Handling Test Runs, Trial Batches and Exploratory Experiments in a Data Integrity Compliant Manner Pharmaceutical manufacturers face increasing regulatory scrutiny regarding data integrity across all stages of production and development. Among the most challenging areas to control are non-routine activities…

Read More “Handling Test Runs, Trial Batches and Exploratory Experiments in a DI-Compliant Way” »

Cloud-Based GxP Systems: Shared Responsibility Models for Data Integrity Cloud-Based GxP Systems: Implementing Shared Responsibility Models for Data Integrity Compliance In the pharmaceutical industry, managing data integrity within cloud-based GxP systems is increasingly critical due to remote operations, evolving technologies, and regulatory scrutiny. Adherence to ALCOA+ principles alongside compliance with US FDA’s 21 CFR Part…

Read More “Cloud-Based GxP Systems: Shared Responsibility Models for Data Integrity” »

Managing Remote Access, VPN and Thin-Client Technologies Under DI Expectations Comprehensive Guide to Managing Remote Access, VPN and Thin-Client Technologies Under Data Integrity Expectations In today’s pharmaceutical manufacturing and clinical operations environments, remote access technologies such as Virtual Private Networks (VPNs) and thin-client solutions play a pivotal role in maintaining operational continuity, supporting decentralized quality…

Read More “Managing Remote Access, VPN and Thin-Client Technologies Under DI Expectations” »

Quality Culture and Data Integrity: How Behaviours Drive Compliance Outcomes Quality Culture and Data Integrity: How Behaviours Drive Compliance Outcomes In the pharmaceutical industry, the integrity of data underpins every regulatory decision, product release, and patient safety measure. Data integrity challenges can compromise GxP records and erode confidence in compliance systems, ultimately risking public health…

Read More “Quality Culture and Data Integrity: How Behaviours Drive Compliance Outcomes” »

Quality Culture and Data Integrity: How Behaviours Drive Compliance Outcomes Building a Robust Quality Culture to Ensure Data Integrity in Pharma Manufacturing In pharmaceutical manufacturing and clinical operations, data integrity forms the backbone of compliance with Good Manufacturing Practice (GMP) and regulatory expectations. Ensuring reliable, accurate, and complete data in GxP records is imperative for…

Read More “Quality Culture and Data Integrity: How Behaviours Drive Compliance Outcomes” »

Designing Data Integrity KPIs and Dashboards for Site and Corporate Management Implementing Effective Data Integrity KPIs and Dashboards: A Step-by-Step Guide for Pharma Management In pharmaceutical manufacturing and clinical operations, maintaining robust data integrity is essential not only for compliance with regulatory frameworks such as 21 CFR Part 11 and Annex 11, but also for…

Read More “Designing Data Integrity KPIs and Dashboards for Site and Corporate Management” »

Handling Misleading, Incomplete or Ambiguous Entries in GMP Records Step-by-Step Guide to Handling Misleading, Incomplete or Ambiguous Entries in GMP Records Good Manufacturing Practice (GMP) records are the cornerstone of pharmaceutical quality systems, ensuring product safety, efficacy, and compliance with regulatory requirements. Accurate and truthful documentation is essential to maintain data integrity across the product…

Read More “Handling Misleading, Incomplete or Ambiguous Entries in GMP Records” »

Root Cause Analysis Techniques Tailored for Data Integrity Incidents Root Cause Analysis Techniques Tailored for Data Integrity Incidents Ensuring robust data integrity is a critical compliance pillar within pharmaceutical Good Manufacturing Practice (GMP). Regulatory frameworks such as 21 CFR Part 11 (US FDA), Annex 11 (EU GMP Volume 4), and PIC/S guidelines emphasize maintaining trustworthy…

Read More “Root Cause Analysis Techniques Tailored for Data Integrity Incidents” »

Building a Data Integrity Heatmap to Prioritize Remediation Activities How to Build a Data Integrity Heatmap to Prioritize Remediation Activities Ensuring data integrity throughout manufacturing and clinical operations is a foundational requirement for pharmaceutical quality systems worldwide. Adherence to principles such as ALCOA+ and compliance with key regulations including 21 CFR Part 11 (US FDA)…

Read More “Building a Data Integrity Heatmap to Prioritize Remediation Activities” »

Data Integrity Considerations in AI-Enabled and Advanced Analytics Platforms Ensuring Robust Data Integrity in AI-Enabled and Advanced Analytics Platforms for Pharma Pharmaceutical manufacturers operating under strict regulatory frameworks in the US, UK, and EU must ensure data integrity throughout their quality and manufacturing systems. The advent of AI-enabled and advanced analytics platforms introduces new challenges…

Read More “Data Integrity Considerations in AI-Enabled and Advanced Analytics Platforms” »